Not just for injury rehabilitation
This article will provide a comprehensive guide from a pharmacist to anyone on a GLP-1 medication or thinking about starting one
The Phase 2 Numbers Amgen reported topline Phase 2 results in November 2025 and presented detailed data at the American Diabetes Association meeting in June 2025
Notably, proglucagon is cleaved in an alternative fashion by PC2 in pancreatic cells to yield glucagon, but not GLP-1/2
Microdosing involves smaller-than-usual doses that still activate GLP-1 receptors to reduce hunger, improve blood sugar balance, and support satiety
Additionally, these medications slow gastric emptying, which contributes to improved postprandial glucose control and promotes satiety, often leading to weight reduction